About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,765 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,765 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 721-740 of 4,765 trials

CompletedA Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic CancerThis study will compare the efficacy and safety of escalating versus standard doses to rash of Tarceva, in combination with gemcitabine, in patients with metastatic pancreatic…NCT00652366·Buenos Aires and 88 others

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

Not yet recruitingA Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic CancerPancreatic cancer, which stands as one of the most lethal malignancies and a leading cause of cancer-related deaths globally, poses a significant challenge to human health…NCT07383922·Shanghai

RecruitingTumor Cell and DNA Detection in the Blood, Urine, and Bone MarrowPatients with resectable solid primary cancers and even limited number of metastases are potentially curable. However, most patients develop recurrences despite surgery.NCT03551951·Columbia, Missouri

UnknownA Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid MalignanciesTo determine the rate of response and the duration of the response following therapy with Aroplatinin patients with advanced solid malignancies.NCT00057395·Santa Monica, California

UnknownLaparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic CancerOpen distal pancreatectomy (ODP) has been commonly employed for the treatment of a variety of cancers in body and tail of pancreas.NCT03792932·Hefei, Anhui and 10 others

UnknownValidations of New cut-of for the Stratification of Postoperative Complications,Drains ManagementPancreatic fistula (PF) represents the Achille's heel of pancreatic surgery and is the main cause of postoperative morbidity since it can determine the onset of others…NCT04380506·Roma

CompletedChemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic CancerThe purpose of this study is to evaluate the clinical effectiveness of Gemcitabine/S-1 combination chemoradiotherapy with Gemcitabine /S-1 combination chemotherapy for…NCT01430052·Osaka

CompletedStudy of Proton Therapy in Adjuvant Pancreatic CancerThis trial aims to determine a safe schedule of short-course proton beam radiation therapy with adjuvant mFOLFIRINOX for patients with resected pancreatic adenocarcinoma.NCT03885284·Washington D.C., District of Columbia

CompletedComparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant TumorsThis study looks at better ways to measure how tumors respond to treatment before surgery.NCT07319767·Shanghai

UnknownCirculating Tumor DNA Exposure in Peripheral BloodThis is a prospective, multi-center, blinded feasibility study.NCT03517332·Tucson, Arizona and 5 others

Active not recruitingCollection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal TractDoctors at Memorial Sloan Kettering Cancer Center and at other institutions study normal and cancer cells.NCT00582647·New York, New York

CompletedEtomidate vs. Midazolam for Sedation During ERCPRecently up-coming drug, etomidate which is a modulator of GABA(gamma-Aminobutyric acid)-A receptor has been known that it maintains the appropriate sedative levels and affects…NCT02027311·Jeju City, Jeju Special Self-Governing Province

CompletedGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsThis phase I clinical trial is studying the side effects and best dose of giving gamma-secretase inhibitor RO4929097 and cediranib maleate together in treating patients with…NCT01131234·Hamilton, Ontario and 1 other

TerminatedEx-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid LesionsThe study investigates the feasibility and the efficacy to treat pancreatic solid lesions as pancreatic adenocarcinomas (PDAC) and neuroendocrine tumors (NET) with ex-vivo…NCT06371716·Milan

RecruitingEvaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero-pancreatic TumorsPrecision medicine is a major goal in oncology. It aims to tailor treatments to the specific characteristics of each patient's tumor.NCT07178587·Brest and 2 others

UnknownA Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous NeoplasmStudy objective: To establish a long-term follow-up cohort of patients with IPMN, study the follow-up, clinical outcomes and prognostic factors of patients with IPMN, and provide…NCT05593393

CompletedGemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerRATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00544193

Active not recruitingNimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic CancerThis is a prospective, open-label, single arm clinical study.NCT06429904·Beijing

CompletedCetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic CancerThis study is designed to establish the safety and efficacy of a combination of Erbitux (cetuximab)/Gemzar (gemcitabine)/radiation in patients with pancreatic cancer.NCT00225784

CompletedTreatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.In Brazil pancreatic adenocarcinoma represents 2% of tumors, and 4% mortality being an uncommon disease, however very aggressive.Only 20% of cases are indicated for curative…NCT01971034·São Paulo, São Paulo

PreviousPage 37 of 239Next